Short answer
DICER1 syndrome genetic testing looks for inherited pathogenic or likely pathogenic variants in DICER1. The result matters most when the personal or family pattern includes pleuropulmonary blastoma, lung cysts in children, thyroid nodules or thyroid cancer, ovarian Sertoli-Leydig cell tumors, cystic nephroma, certain eye or brain tumors, or other tumors in the DICER1 spectrum. A DICER1 result found only in tumor tissue is not automatically inherited, and a DICER1 VUS should not be treated like a confirmed harmful variant.
How to read the result
| Report wording | Practical meaning | What to ask next |
|---|---|---|
| Pathogenic or likely pathogenic germline DICER1 variant | The lab found an inherited DICER1 change with enough evidence to guide syndrome-level counseling. | Which lung, thyroid, ovarian, kidney, eye, brain, and family-testing conversations apply to this exact result? |
| DICER1 variant of uncertain significance | The lab found a DICER1 change, but its health meaning is not established. | Should care be based on personal and family history while the variant remains uncertain? |
| Negative DICER1 result | No reportable DICER1 variant was found in the test performed. | Was there a known family variant, and did the clinical or tumor pattern suggest other testing? |
| Tumor-only DICER1 finding | The DICER1 change may be present only in tumor tissue rather than inherited DNA. | Is separate germline testing needed before relatives are told they may be at inherited risk? |
| Family variant testing | Relatives may be offered targeted testing when a confirmed familial pathogenic DICER1 variant is known. | Does the report name the exact familial variant relatives should be tested for? |
Tumor-pattern context to clarify
- GeneReviews describes DICER1-related tumor predisposition as a spectrum of benign and malignant tumors, with pleuropulmonary blastoma, Sertoli-Leydig cell tumors, pediatric cystic nephroma, and differentiated thyroid carcinoma among recognized findings.
- MedlinePlus highlights pleuropulmonary blastoma as a common tumor in DICER1 syndrome and notes thyroid, ovarian, kidney, eye, and other tumor associations.
- NCI defines DICER1 syndrome as a rare inherited disorder caused by a DICER1 gene change, with tumors that may be benign or malignant.
- Age matters. GeneReviews notes priority situations for testing in young children and young girls or women because some risks and surveillance questions are time-sensitive.
- A negative result is most reassuring when a known familial DICER1 variant was specifically tested. Without a known family variant, it may be an uninformative negative.
Questions to bring to counseling
- Was DICER1 tested from blood, saliva, cheek cells, tumor tissue, or paired tumor-normal testing?
- What is the exact DICER1 variant notation and classification?
- Does the personal or family history include pleuropulmonary blastoma, lung cysts, thyroid nodules, ovarian Sertoli-Leydig cell tumor, cystic nephroma, or other DICER1-spectrum findings?
- Does the person's age change which surveillance or testing conversations are time-sensitive?
- Should children, siblings, parents, or other relatives have targeted testing for a known family variant?
- Could a tumor-only result require germline confirmation before family-risk decisions are made?
- How will I be notified if a DICER1 VUS is reclassified?
When follow-up matters more
Follow-up becomes more important when the tumor history fits the DICER1 spectrum, when age makes surveillance time-sensitive, when a tumor-only finding needs germline confirmation, or when relatives may need testing. In those situations, the result should sharpen the tumor-pattern picture rather than stand in for a full counseling review.
Related guides: hereditary cancer genetic testing, tumor genomic vs inherited genetic testing, BAP1 tumor predisposition genetic testing, SMARCA4 rhabdoid tumor predisposition genetic testing, and when to use a genetic counselor.
What the result still cannot prove
A DICER1 result can support a tumor-predisposition diagnosis, but it does not by itself predict every tumor or replace age-based and symptom-based surveillance decisions.
FAQ
Does DICER1 only matter in childhood?
No. DICER1-related tumors often appear earlier in life, but adults can still be affected and may still need family-aware counseling.
Does a DICER1 VUS change surveillance?
No. A variant of uncertain significance should not be treated like a confirmed pathogenic result.
Does a negative DICER1 result rule out the syndrome?
Not always. A negative result does not fully rule it out if the phenotype still fits and the test did not capture every possibility.
Does tumor-only DICER1 prove inherited syndrome?
No. A tumor finding can help explain the cancer, but it does not by itself prove germline DICER1 syndrome.
Should relatives be tested?
If a familial pathogenic DICER1 variant is known, targeted testing may be discussed for relatives.
What should counseling clarify first?
The exact tumor type, age at diagnosis, family history, and whether thyroid, ovarian, lung, or other DICER1-pattern findings are present.